Tripple negative breast cancer is harder to treat as the tumors don’t have the receptors that the common drugs such as oestrogen, progesterone or HER2 that are targeted by common treatments such as hormone therapy or Herceptin can target blocking the growth of the tumor. The gene discussed is ERBB2; the disease is neoplasm.